US20100089287A1 - Soy protein adhesive and uses thereof - Google Patents

Soy protein adhesive and uses thereof Download PDF

Info

Publication number
US20100089287A1
US20100089287A1 US12/586,739 US58673909A US2010089287A1 US 20100089287 A1 US20100089287 A1 US 20100089287A1 US 58673909 A US58673909 A US 58673909A US 2010089287 A1 US2010089287 A1 US 2010089287A1
Authority
US
United States
Prior art keywords
acid
soy protein
enzyme
mixture
adhesive composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/586,739
Other languages
English (en)
Inventor
Shelby F. Thames
James W. Rawlins
Richard C. Ferguson
Sharathkumar K. Mendon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SOUTHERN MISSISSIPPI THE, University of
Original Assignee
SOUTHERN MISSISSIPPI THE, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SOUTHERN MISSISSIPPI THE, University of filed Critical SOUTHERN MISSISSIPPI THE, University of
Priority to US12/586,739 priority Critical patent/US20100089287A1/en
Assigned to UNIVERSITY OF SOUTHERN MISSISSIPPI, THE reassignment UNIVERSITY OF SOUTHERN MISSISSIPPI, THE ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FERGUSON, RICHARD C., MENDON, SHARATHKUMAR K., RAWLINS, JAMES W., THAMES, SHELBY F.
Publication of US20100089287A1 publication Critical patent/US20100089287A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Definitions

  • the present invention relates to soy protein-based adhesive compositions and a process for making such compositions that may be used in making particleboard and similar wood composite systems.
  • the invention is further directed to particleboard and similar composite systems made with such adhesive composites.
  • the present invention utilizes enzymatically-modified soy proteins.
  • Soy and other protein-based adhesives have been used in composite wood systems prior to the advent of synthetic resins such as urea formaldehyde-based resins.
  • the synthetic resins became popular as they offered better moisture resistance and lower press times.
  • the demand for natural, environmentally-friendly wood composite adhesive compositions has been ever-increasing, due also in part to the known hazards of formaldehyde-based adhesives.
  • the use of natural soy protein-based adhesives in wood composites that also resist water intrusion must result in composites that at a minimum meet or exceed the composites that utilize urea formaldehyde.
  • the present invention that uses an enzymatically-modified soy protein satisfies these requirements.
  • Wood composite panels are typically formed by combining appropriate wood furnish with suitable polymeric adhesives, forming them into a mat, and finally thermally curing them under pressure.
  • suitable polymeric adhesives employ formaldehyde-based resins.
  • a wood adhesive must wet wood substrates efficiently, adhere or glue particles together and, in the process, establish inter-particle bonds that create strong, water-resistant wood composites.
  • particleboard manufacture employs urea formaldehyde (UF) resins that are typically supplied at 65 weight % solids and used at levels of 6-10 weight % of dry resin on wood furnish.
  • UF formaldehyde
  • formaldehyde-based resins may be efficient and cost effective as adhesives, the toxicity and carcinogenicity of formaldehyde to humans is a serious health concern, according to the International Agency for Research on Cancer (IARC).
  • IARC International Agency for Research on Cancer
  • Formaldehyde has a pungent, irritating odor even at very low concentrations ( ⁇ 1 ppm).
  • Individuals sensitized to formaldehyde may experience headaches and minor eye and airway irritation at levels below the odor threshold.
  • Low-dose acute exposure can result in headache, rhinitis, and dyspnea, while higher doses may cause severe mucous membrane irritation, burning, lachrymation, and lower respiratory effects such as bronchitis, pulmonary edema, or pneumonia.
  • the present invention provides such an adhesive composition which utilizes an aqueous mixture with a soy protein modified by an enzyme, specifically urease, and provides a process to make such composition and novel wood composite systems produced by such process and using the novel adhesive composition.
  • the present invention is directed to a soy protein-based adhesive composition, process for making the composition and a process for making the composition.
  • the composition of the present invention comprises an aqueous mixture of calcium oxide, pine oil, soy protein, lignin, and acid, where the soy protein is modified by an enzyme, specifically urease.
  • the acid can be an organic or inorganic acid.
  • the adhesive composition can be mixed with a source of lignocellulose to make particleboard or other wood composite systems.
  • the adhesive composition of the present invention is an aqueous mixture of calcium oxide, pine oil, protein, lignin, and acid.
  • the composition can be mixed with wood furnish or other source of lignocellulose to produce improved particleboard or other similar wood composite systems that are formaldehyde-free.
  • the composition comprises a mixture of water, calcium oxide, pine oil, soy protein, lignin, and acid, where the soy protein is modified by an enzyme, specifically urease.
  • the soy protein can be soybean or similar protein.
  • the acid can be an organic or inorganic acid.
  • the mixture comprises inorganic nitric acid as the preferred acid.
  • the urease enzyme-modified soy protein of the mixture enables much higher solids content for the mixture and provides much improved particleboard and particleboard performance by reducing water quantity in the process of manufacture, which in turn reduces processing time and increases particleboard strength.
  • the pine oil of the mixture of the present invention acts as a natural product defoamer (for improved foam reduction) and prevents microbial degradation (for improved storage stability) of the novel adhesive composition.
  • U.S. Pat. No. 7,081,159 urea-formaldehyde
  • the present invention is a vast improvement over the formaldehyde-based adhesives and over the soybean protein-based adhesive described in U.S. Pat. No. 7,081,159, which is limited to 30% solids with a paste-like consistency.
  • an aqueous dispersion of soybean protein is a poor adhesive as the majority of polar and non-polar groups are rendered unavailable for wood particle wetting and adhesion.
  • Enzymatic modification of proteins can be tailored to minimize undesired side reactions and improve access to protein functional groups. For instance, trypsin is known to hydrolyze peptide bonds containing basic amino acids such as lysine or arginine. Chymotrypsin, pepsin, and papain each selectively catalyze the hydrolysis of peptide bonds in different regions of the protein. There are currently no known reports of enzymatically modifying soybean protein to achieve improved adhesive properties for use in particleboards.
  • the present invention has proven significant success in enzymatically modifying commercially available soybean protein grades as the sole binder for use in adhesive formulations through selective chain scission where the adhesive processing characteristics and bond strengths are improved as molecular weight is reduced, which is an unexpected but highly desirable consequence.
  • an aqueous dispersion of soybean protein was blended with the enzyme urease at various weight ratios for 2.5 hours at 1200 rpm (pH 8, 37° C.).
  • the enzyme was deactivated by raising the system pH to 11, and the hydrolyzed blend was processed to an adhesive using a standard formulation.
  • the modification enabled the synthesis of adhesives with 45% solids while achieving lower viscosity than previously achieved.
  • Adhesive compositions prepared from the urease-modified soy protein were processed into particleboards using a 24-inch by 24-inch press with an initial pressure of 2500-3000 psi maintained for 300-360 seconds at 193° C. The particleboards were then evaluated for density, modulus of rupture (MOR), modulus of elasticity (MOE), and internal bond strength (IB) (Table 1).
  • Time Step Detail 0:00 1 Charge reactor (reaction kettle) with water and adjust to pH 8 using ammonia. 0:05 2 Place in a water bath at 37 ⁇ 2° C., initiate agitation at 100 RPM, and allow the temperature to stabilize for 15 minutes. 0:20 3 Add the enzyme and increase agitation to 300 RPM. 0:35 4 Allow mixture to stir for 25 minutes. 1:00 5 Add 50% of the protein over 15 minutes. 1:15 6 Add the remaining protein slowly, taking care to ensure that it is blended completely. Gradually increase stirring speed to 1200 RPM. 2:00 7 Allow the mixture to stir for an additional 90 minutes. 3:30 8 Raise the temperature to 68 ⁇ 2° C., and charge reactor with calcium oxide and pine oil.
  • particleboards During particleboard manufacture, the core tightens less than either surface that is in contact with the press platens; therefore, its strength is also lower than that of the surface.
  • the IB value of particleboards is often therefore a better indicator of particleboard performance than MOR and MOE. It has been shown that particleboards with similar MOR and MOE values displayed varying LB values that were related to differences in the manufacturing process.
  • the data disclosed reveal that the urease soybean protein modification of the present invention at weight ratio of 250:1 resulted in particleboards that were totally free of synthetic formaldehyde precursors and met and/or exceeded ANSI specifications for MOR and MOE, as well as outperformed commercial particleboards. More importantly, the IB values of particleboards formulated with the urease modified soybean protein adhesive of the present invention far exceeded the IB values of either commercial particleboards or ANSI specifications.
  • the particleboards having high IB values imparted by the urease-modified soybean protein adhesive composition of the present invention are a significant improvement over current particleboards and represent a step change in particleboard technology.
  • the present invention has for the first time described and fully characterized an improved soy protein-based adhesive composition, process for making the composition, and wood composite system made with the adhesive composition.
  • the above detailed description is presented to enable any person skilled in the art to make and use the invention. Specific details have been disclosed to provide a comprehensive understanding of the present invention and are used for explanation of the information provided. Descriptions of specific applications are meant to serve only as representative examples. Various suitable changes, modifications, combinations, and equivalents to the preferred embodiments may be readily apparent to one skilled in the art and the general principles defined herein may be applicable to other embodiments and applications while still remaining within the spirit and scope of the invention. The claims and specification should not be construed to unduly narrow the complete scope of protection to which the present invention is entitled.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Adhesives Or Adhesive Processes (AREA)
US12/586,739 2008-09-25 2009-09-25 Soy protein adhesive and uses thereof Abandoned US20100089287A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/586,739 US20100089287A1 (en) 2008-09-25 2009-09-25 Soy protein adhesive and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10017608P 2008-09-25 2008-09-25
US12/586,739 US20100089287A1 (en) 2008-09-25 2009-09-25 Soy protein adhesive and uses thereof

Publications (1)

Publication Number Publication Date
US20100089287A1 true US20100089287A1 (en) 2010-04-15

Family

ID=42060336

Family Applications (8)

Application Number Title Priority Date Filing Date
US12/586,739 Abandoned US20100089287A1 (en) 2008-09-25 2009-09-25 Soy protein adhesive and uses thereof
US12/612,584 Expired - Fee Related US8114600B2 (en) 2008-09-25 2009-11-04 Genetic markers of schizophrenia endophenotypes
US12/612,582 Abandoned US20100105062A1 (en) 2008-09-25 2009-11-04 Genetic Markers for Optimizing Treatment for Schizophrenia
US12/612,521 Expired - Fee Related US8129117B2 (en) 2008-09-25 2009-11-04 Genetic markers for assessing risk of developing bipolar disorder
US12/612,585 Abandoned US20100119626A1 (en) 2008-09-25 2009-11-04 Genetic Markers for Assessing Risk of Developing Schizophrenia
US13/344,123 Abandoned US20120100637A1 (en) 2008-09-25 2012-01-05 Genetic markers of schizophrenia endophenotypes
US13/360,037 Abandoned US20120129171A1 (en) 2008-09-25 2012-01-27 Genetic Markers for Assessing Risk of Developing Bipolar Disorder
US14/458,854 Abandoned US20140350000A1 (en) 2008-09-25 2014-08-13 Genetic Markers for Optimizing Treatment for Schizophrenia

Family Applications After (7)

Application Number Title Priority Date Filing Date
US12/612,584 Expired - Fee Related US8114600B2 (en) 2008-09-25 2009-11-04 Genetic markers of schizophrenia endophenotypes
US12/612,582 Abandoned US20100105062A1 (en) 2008-09-25 2009-11-04 Genetic Markers for Optimizing Treatment for Schizophrenia
US12/612,521 Expired - Fee Related US8129117B2 (en) 2008-09-25 2009-11-04 Genetic markers for assessing risk of developing bipolar disorder
US12/612,585 Abandoned US20100119626A1 (en) 2008-09-25 2009-11-04 Genetic Markers for Assessing Risk of Developing Schizophrenia
US13/344,123 Abandoned US20120100637A1 (en) 2008-09-25 2012-01-05 Genetic markers of schizophrenia endophenotypes
US13/360,037 Abandoned US20120129171A1 (en) 2008-09-25 2012-01-27 Genetic Markers for Assessing Risk of Developing Bipolar Disorder
US14/458,854 Abandoned US20140350000A1 (en) 2008-09-25 2014-08-13 Genetic Markers for Optimizing Treatment for Schizophrenia

Country Status (3)

Country Link
US (8) US20100089287A1 (de)
EP (5) EP2868753A1 (de)
WO (4) WO2010036965A2 (de)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8680224B2 (en) 2010-02-01 2014-03-25 Johns Manville Formaldehyde-free protein-containing binder compositions
US8809477B2 (en) 2010-02-01 2014-08-19 Johns Manville Formaldehyde-free protein-containing binder compositions
US8937025B2 (en) 2010-02-01 2015-01-20 Johns Manville Formaldehyde-free protein-containing binders for spunbond products
US9522515B2 (en) 2011-06-17 2016-12-20 The Governors Of The University Of Alberta Adhesives derived from agricultural proteins
US9683085B2 (en) 2010-02-01 2017-06-20 Johns Manville Formaldehyde-free protein-containing binders for spunbond products
US10266694B2 (en) 2015-03-12 2019-04-23 Auburn University Use of soy flour in resin formulations used to manufacture engineered wood composites
US10851132B2 (en) 2015-08-26 2020-12-01 Sewon Biotechnology Inc. Protein based adhesive composition and method
US10899039B2 (en) 2016-03-16 2021-01-26 Auburn University Soy-modified resins for bonding wood
SE2150391A1 (en) * 2021-03-30 2022-10-01 Organoclick Ab Adhesive composition comprising lupine protein and lignin

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7702468B2 (en) 2006-05-03 2010-04-20 Population Diagnostics, Inc. Evaluating genetic disorders
US10522240B2 (en) 2006-05-03 2019-12-31 Population Bio, Inc. Evaluating genetic disorders
EP2581459A3 (de) 2008-01-17 2013-07-17 Suregene LLC Genetische Marker von Geisteskrankheiten
US7951542B2 (en) 2009-11-04 2011-05-31 Surgene, LLC Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
US7951543B2 (en) 2009-11-04 2011-05-31 Suregene, Llc Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
US7985551B2 (en) 2009-11-04 2011-07-26 Suregene, Llc Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
US7972793B2 (en) 2009-11-04 2011-07-05 Suregene, Llc Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
CN103392182B (zh) 2010-08-02 2017-07-04 众有生物有限公司 用于发现遗传疾病中致病突变的系统和方法
US7932042B1 (en) 2010-10-13 2011-04-26 Suregene, Llc Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor genetic signature
WO2012094681A1 (en) * 2011-01-07 2012-07-12 The Trustees Of Columbia University In The City Of New York Compositions and methods for the diagnosis of schizophrenia
WO2013003801A2 (en) 2011-06-29 2013-01-03 The Trustees Of Columbia University In The City Of New York Inhibitor of neuronal connectivity linked to schizophrenia susceptibility and cognitive dysfunction
US10221454B2 (en) 2011-10-10 2019-03-05 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders
US11180807B2 (en) 2011-11-04 2021-11-23 Population Bio, Inc. Methods for detecting a genetic variation in attractin-like 1 (ATRNL1) gene in subject with Parkinson's disease
CA2863887C (en) 2012-02-09 2023-01-03 Population Diagnostics, Inc. Methods of screening low frequency gdna variation biomarkers for pervasive developmental disorder (pdd) or pervasive developmental disorder - not otherwise specified (pdd_nos)
DK2895621T3 (da) 2012-09-14 2020-11-30 Population Bio Inc Fremgangsmåder og sammensætning til diagnosticering, prognose og behandling af neurologiske tilstande
US10233495B2 (en) 2012-09-27 2019-03-19 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders
JP6695142B2 (ja) * 2013-01-25 2020-05-20 ウニベルシタット、デ、バルセロナUniversitat De Barcelona 抗精神病薬に基づく処置により誘導される錐体外路症状(eps)の発症を予測する方法
US20160273042A1 (en) * 2013-11-07 2016-09-22 Clinical Reference Laboratory, Inc. Genetic markers of antipsychotic response
WO2016036403A1 (en) 2014-09-05 2016-03-10 Population Diagnostics Inc. Methods and compositions for inhibiting and treating neurological conditions
US11111279B2 (en) 2015-11-20 2021-09-07 Grand Valley State University Nato3 mutant polypeptides and uses thereof
WO2017165423A1 (en) * 2016-03-21 2017-09-28 Indiana University Research & Technology Corporation Drugs, pharmacogenomics and biomarkers for active longevity
US10171034B2 (en) 2016-04-08 2019-01-01 Mediatek Inc. Phase-rotated harmonic-rejection mixer apparatus
US10009050B2 (en) * 2016-05-26 2018-06-26 Mediatek Singapore Pte. Ltd. Quadrature transmitter, wireless communication unit, and method for spur suppression
WO2017209426A1 (ko) * 2016-06-02 2017-12-07 국립암센터 Fam188b의 발현 억제제 또는 활성 억제제를 포함하는 항암 또는 항암보조제 조성물
MX2019005937A (es) 2016-11-22 2019-11-18 Janssen Pharmaceutica Nv Metodos para identificar pacientes de esquizofrenia en riesgo de recaer.
US10240205B2 (en) 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test
WO2018178071A1 (en) 2017-03-29 2018-10-04 Consejo Superior De Investigaciones Cientificas Method for predicting the therapeutic response to antipsychotic drugs
HRP20221504T1 (hr) 2018-08-08 2023-03-31 Pml Screening, Llc Postupci procjene rizika od razvoja progresivne multifokalne leukoencefalopatije uzrokovane john cunningham virusom pomoću genetskog testiranja
CN109543658A (zh) * 2018-12-25 2019-03-29 中国政法大学 智能审讯辅助方法及装置
FR3107708A1 (fr) 2020-02-28 2021-09-03 Alganelle Microalgue recombinante capable de produire des peptides, polypeptides et protéines de KTTKS et leurs dérivés, et leurs procédé et utilisations associés
DE102020005556B4 (de) 2020-09-02 2023-07-06 Gesellschaft für Individualisierte Medizin mbH Verfahren zur Prognose der Schwere des Verlaufs einer COVID-19-Erkrankung
US20220403469A1 (en) * 2021-06-17 2022-12-22 United States Government As Represented By The Department Of Veterans Affairs Precision Medicine for Schizophrenia and Psychotic Disorders: Objective Assessment, Risk Prediction, Pharmacogenomics, and Repurposed Drugs
WO2023235415A1 (en) * 2022-06-01 2023-12-07 Genentech, Inc. Method to identify a patient with an increased likelihood of chemotherapy-induced peripheral neuropathy

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352692A (en) * 1981-03-16 1982-10-05 Ralston Purina Company Modified vegetable protein adhesive binder
US7081159B2 (en) * 2004-03-19 2006-07-25 The University Of Southern Mississippi Soy protein based adhesive and particleboard

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5527681A (en) 1989-06-07 1996-06-18 Affymax Technologies N.V. Immobilized molecular synthesis of systematically substituted compounds
DK0747485T3 (da) 1989-11-06 1999-08-16 Cell Genesys Inc Fremstilling af proteiner ved anvendelse af homolog rekombination
US5252743A (en) 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
US5272071A (en) 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
US5288644A (en) 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
US5491224A (en) 1990-09-20 1996-02-13 Bittner; Michael L. Direct label transaminated DNA probe compositions for chromosome identification and methods for their manufacture
JPH06504997A (ja) 1990-12-06 1994-06-09 アフィメトリックス, インコーポレイテッド 非常に大きい規模の固定化されたポリマーの合成
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
US5288514A (en) 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
WO1995011995A1 (en) 1993-10-26 1995-05-04 Affymax Technologies N.V. Arrays of nucleic acid probes on biological chips
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
WO1998020019A1 (en) 1996-11-06 1998-05-14 Sequenom, Inc. Compositions and methods for immobilizing nucleic acids to solid supports
US5800998A (en) 1996-11-12 1998-09-01 Millennium Pharmaceuticals, Inc. Assays for diagnosing type II diabetes in a subject
US6723564B2 (en) 1998-05-07 2004-04-20 Sequenom, Inc. IR MALDI mass spectrometry of nucleic acids using liquid matrices
US6912492B1 (en) * 1999-05-25 2005-06-28 University Of Medicine & Dentistry Of New Jersey Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors
US20030008301A1 (en) * 2001-02-02 2003-01-09 Pamela Sklar Association between schizophrenia and a two-marker haplotype near PILB gene
US20030224365A1 (en) * 2001-04-24 2003-12-04 Wood Linda Susan Single nucleotide polymorphisms diagnostic for schizophrenia
WO2003039234A2 (en) 2001-11-06 2003-05-15 David Pickar Pharmacogenomics-based system for clinical applications
US20080206242A1 (en) * 2002-03-01 2008-08-28 Xencor, Inc. Method of treatment of th2-mediated conditions using optimized anti-cd30 antibodies
EP1578354A4 (de) 2002-03-26 2008-04-09 Massachusetts Inst Technology Targets, verfahren und reagenzien für die diagnose und behandlung von schizophrenie
US20060072075A1 (en) * 2002-12-11 2006-04-06 Koninklijke Philips Electronics N.V. Projection system with contrast homogeneity correction
US20040210400A1 (en) * 2003-01-27 2004-10-21 Perlegen Sciences, Inc. Analysis methods for individual genotyping
CA2555138A1 (en) * 2004-02-06 2005-08-25 Virologic, Inc. Method for determining reduced susceptibility of hiv to protease inhibitor treatment
CA2592473A1 (en) 2004-12-30 2006-07-06 University Of Louisville Research Foundation, Inc. Genetic markers of schizophrenia
US20090305246A1 (en) * 2005-10-17 2009-12-10 Bernard Lerer Schizophrenia associated genes and markers
US7702468B2 (en) * 2006-05-03 2010-04-20 Population Diagnostics, Inc. Evaluating genetic disorders
US20080199866A1 (en) * 2006-10-10 2008-08-21 The Board Of Trustees Of The Leland Stanford Junior University Snp detection and other methods for characterizing and treating bipolar disorder and other ailments
CA2664366C (en) * 2006-11-09 2018-09-04 Centre For Addiction And Mental Health Slc1a1 antipsychotic drug response markers
US20080206768A1 (en) * 2006-12-18 2008-08-28 Maria Arranz Predicting a response to olanzapine
US8067160B2 (en) 2007-07-06 2011-11-29 University Of Louisville Research Foundation, Inc. Genetic markers of schizophrenia
WO2009082743A2 (en) 2007-12-24 2009-07-02 Suregene Llc Genetic markers for schizophrenia and bipolar disorder
EP2570495B1 (de) 2008-01-02 2015-09-09 SureGene LLC Genetische Marker für Geisteskrankheiten
EP2581459A3 (de) 2008-01-17 2013-07-17 Suregene LLC Genetische Marker von Geisteskrankheiten
JP2016031772A (ja) 2014-07-30 2016-03-07 株式会社日立ハイテクファインシステムズ 熱アシスト磁気ヘッド素子の検査方法及びその装置

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352692A (en) * 1981-03-16 1982-10-05 Ralston Purina Company Modified vegetable protein adhesive binder
US7081159B2 (en) * 2004-03-19 2006-07-25 The University Of Southern Mississippi Soy protein based adhesive and particleboard

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Kumar et al, "Ensymatically-modified soy protein part 2: adhesion behaviour", J. Adhesion Sci. Technol., Vol.18, No.2, pp261-273 (2004) *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9683085B2 (en) 2010-02-01 2017-06-20 Johns Manville Formaldehyde-free protein-containing binders for spunbond products
US8809477B2 (en) 2010-02-01 2014-08-19 Johns Manville Formaldehyde-free protein-containing binder compositions
US8937025B2 (en) 2010-02-01 2015-01-20 Johns Manville Formaldehyde-free protein-containing binders for spunbond products
US9493617B2 (en) 2010-02-01 2016-11-15 Johns Manville Formaldehyde-free protein-containing binder compositions
US9587103B2 (en) 2010-02-01 2017-03-07 Johns Manville Formaldehyde-free protein-containing binder compositions
US8680224B2 (en) 2010-02-01 2014-03-25 Johns Manville Formaldehyde-free protein-containing binder compositions
US9522515B2 (en) 2011-06-17 2016-12-20 The Governors Of The University Of Alberta Adhesives derived from agricultural proteins
US10266694B2 (en) 2015-03-12 2019-04-23 Auburn University Use of soy flour in resin formulations used to manufacture engineered wood composites
US10851132B2 (en) 2015-08-26 2020-12-01 Sewon Biotechnology Inc. Protein based adhesive composition and method
US10899039B2 (en) 2016-03-16 2021-01-26 Auburn University Soy-modified resins for bonding wood
SE2150391A1 (en) * 2021-03-30 2022-10-01 Organoclick Ab Adhesive composition comprising lupine protein and lignin
WO2022211700A1 (en) 2021-03-30 2022-10-06 Organoclick Ab Adhesive composition comprising lupine protein and lignin
SE544971C2 (en) * 2021-03-30 2023-02-14 Organoclick Ab Adhesive composition comprising lupine protein and lignin

Also Published As

Publication number Publication date
EP2331709B1 (de) 2013-05-29
EP2344672B1 (de) 2014-11-12
EP2342361A2 (de) 2011-07-13
US20100105062A1 (en) 2010-04-29
WO2010036965A2 (en) 2010-04-01
US20140350000A1 (en) 2014-11-27
EP2344672A2 (de) 2011-07-20
US20100119626A1 (en) 2010-05-13
WO2010036943A2 (en) 2010-04-01
US20100119625A1 (en) 2010-05-13
WO2010036965A3 (en) 2010-10-07
WO2010036943A3 (en) 2010-10-21
US20120129171A1 (en) 2012-05-24
WO2010036353A9 (en) 2010-07-01
US8129117B2 (en) 2012-03-06
EP2331709A2 (de) 2011-06-15
WO2010036969A2 (en) 2010-04-01
EP2342361A4 (de) 2012-11-14
EP2631303A1 (de) 2013-08-28
EP2868753A1 (de) 2015-05-06
EP2344672A4 (de) 2012-11-28
US20120100637A1 (en) 2012-04-26
US8114600B2 (en) 2012-02-14
WO2010036353A2 (en) 2010-04-01
WO2010036969A3 (en) 2010-10-07
US20100120046A1 (en) 2010-05-13
EP2331709A4 (de) 2012-02-15
EP2344672B8 (de) 2014-12-24

Similar Documents

Publication Publication Date Title
US20100089287A1 (en) Soy protein adhesive and uses thereof
Lambuth Protein adhesives for wood
US7081159B2 (en) Soy protein based adhesive and particleboard
CN100556974C (zh) 一种水性无醛粘合剂及其制备方法
US9234100B2 (en) Chitosan-based adhesives and uses thereof
CN101475790A (zh) 新型木材胶粘剂及其制备方法
US10087350B2 (en) Formaldehyde-free protein-containing binder compositions
CN108727546B (zh) 一种聚合反应型甲醛捕捉剂及其制备方法
CN101928546A (zh) 一种无甲醛木材胶粘剂及其制备方法
US5281434A (en) Composition and process of making an animal feed binder composed of ozonated lignosulfonate
US6489392B1 (en) Foamed resin adhesive and the use thereof of glueing wood based panels and boards
BRPI0912801B1 (pt) Processo para preparar uma resina de melamina-uréia-formaldeído, resina de melamina-uréia-formaldeído, e, artigo de fabricação
CA2244667C (en) Bonding agent composition, its use as well as a process for the production of particle board
NZ210396A (en) Preparation of urea-formaldehyde resins
US3905921A (en) Rapidly-foamable, fast-setting phenolic resin plywood glue
US5324590A (en) Foamed adhesive for particleboard
CN102399514B (zh) 一种甲醛消除剂及其制备方法
CN102952409A (zh) 一种人造板用防水、防霉剂及其制备方法
CA2122368A1 (en) Method for the production of particle- or fiberboard
US2592510A (en) Adhesive composition and process of preparing the same
US20040173306A1 (en) Particleboard and method for forming a particleboard
CN109825248B (zh) 一种改性大豆蛋白胶粘剂及其制备方法
CN102391796B (zh) 脲醛树脂添加剂、制备方法及其应用
US2895928A (en) Resin-blood glue and process of making the same
US5719222A (en) Water-based synthetic adhesive and method for making the same

Legal Events

Date Code Title Description
AS Assignment

Owner name: UNIVERSITY OF SOUTHERN MISSISSIPPI, THE,MISSISSIPP

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:THAMES, SHELBY F.;RAWLINS, JAMES W.;FERGUSON, RICHARD C.;AND OTHERS;REEL/FRAME:023661/0338

Effective date: 20091028

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION